SARA RIEHN: Open Payments
NPI 1538204581 · LAWRENCE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$583 in 37 payments from 10 companies in 2025. Trend: 2023 $495 · 2024 $585 · 2025 $583
Food & beverage: $498Education: $85
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $175 |
| ABBVIE INC. | 13 | $136 |
| Novo Nordisk Inc | 5 | $83 |
| Lilly USA, LLC | 4 | $58 |
| Seqirus USA Inc | 2 | $48 |
| Boston Scientific Corporation | 1 | $23 |
| Amgen Inc. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
| Insulet Corporation | 1 | $14 |
Products named: Veozah, QULIPTA, Ozempic, UBRELVY, JARDIANCE, MOUNJARO, Flucelvax, WATCHMAN FLX.
Industry payments across KS — which companies pay providers there.
